IN8bio Hires Oxana Polyakova as SVP of R&D — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- IN8bio hired Oxana Polyakova as senior vice president of research & development, filling out its R&D leadership bench
- Oxana Polyakova joins IN8bio from LAVA Therapeutics, where her prior role was chief scientific officer
- The hire is the featured item in STAT's recurring weekly "Up and down the ladder" column that tracks biopharma personnel moves
- STAT frames the column as reader-submitted, inviting companies to send in their own hires, promotions, and backfills for inclusion in future editions
- The full edition of the column — presumably with additional personnel moves beyond Polyakova — sits behind the STAT+ paywall
Why it matters: STAT's weekly column has become a clearinghouse for biotech executive moves, with this edition's lead item showing IN8bio recruiting a CSO-level operator from peer LAVA Therapeutics to oversee research. For industry readers, the paywalled full listing is positioned as the curated view of who is moving where across biopharma that week.
Ask SkimNews